Chemfab Alkalis Ltd
Incorproated in 2009, Chemfab
Alkalis Ltd manufactures basic
inorganic chemicals and PVCO
pipes[1]
- Market Cap ₹ 526 Cr.
- Current Price ₹ 366
- High / Low ₹ 849 / 270
- Stock P/E
- Book Value ₹ 261
- Dividend Yield 0.34 %
- ROCE 1.55 %
- ROE -0.91 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.5% over past five years.
- Company has a low return on equity of 2.71% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 205 | 181 | 272 | 331 | 327 | 334 | 311 | |
| 149 | 157 | 215 | 221 | 273 | 290 | 284 | |
| Operating Profit | 55 | 24 | 57 | 111 | 55 | 44 | 27 |
| OPM % | 27% | 13% | 21% | 33% | 17% | 13% | 9% |
| -0 | 1 | 6 | 2 | 9 | -3 | 9 | |
| Interest | 4 | 3 | 1 | 1 | 2 | 6 | 8 |
| Depreciation | 25 | 20 | 22 | 23 | 22 | 36 | 28 |
| Profit before tax | 27 | 2 | 39 | 89 | 39 | -0 | -0 |
| Tax % | 5% | 500% | 26% | 28% | 33% | 2,210% | 1,615% |
| 25 | -8 | 29 | 65 | 26 | -7 | -3 | |
| EPS in Rs | 18.26 | -5.78 | 20.34 | 45.54 | 18.50 | -4.83 | -2.39 |
| Dividend Payout % | 7% | 0% | 6% | 3% | 7% | -26% | -52% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | -2% |
| TTM: | -7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | % |
| TTM: | -138% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 1% |
| 1 Year: | -53% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 3% |
| Last Year: | -1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 262 | 253 | 284 | 347 | 373 | 366 | 361 |
| 43 | 32 | 9 | 2 | 20 | 84 | 126 | |
| 30 | 36 | 46 | 48 | 93 | 57 | 76 | |
| Total Liabilities | 348 | 335 | 352 | 412 | 500 | 522 | 577 |
| 195 | 202 | 194 | 192 | 247 | 317 | 387 | |
| CWIP | 35 | 3 | 8 | 31 | 74 | 36 | 31 |
| Investments | 1 | 24 | 31 | 68 | 5 | 16 | 14 |
| 118 | 105 | 119 | 121 | 174 | 152 | 146 | |
| Total Assets | 348 | 335 | 352 | 412 | 500 | 522 | 577 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 54 | 45 | 55 | 93 | 31 | 40 | 38 | |
| -58 | -6 | -21 | -48 | -110 | -86 | -81 | |
| 3 | -16 | -25 | -9 | 16 | 59 | 31 | |
| Net Cash Flow | -1 | 23 | 9 | 36 | -62 | 13 | -12 |
| Free Cash Flow | -4 | 38 | 35 | 40 | -60 | -71 | -38 |
| CFO/OP | 110% | 157% | 107% | 97% | 74% | 104% | 140% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 31 | 29 | 24 | 24 | 23 | 28 |
| Inventory Days | 84 | 79 | 54 | 89 | 60 | 100 | 92 |
| Days Payable | 165 | 154 | 92 | 145 | 101 | 118 | 111 |
| Cash Conversion Cycle | -63 | -45 | -9 | -32 | -18 | 4 | 9 |
| Working Capital Days | -2 | 15 | 5 | 7 | -24 | 28 | 15 |
| ROCE % | 2% | 13% | 28% | 10% | 3% | 2% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Caustic Soda Installed Capacity TPA |
|
|||||||||
| OPVC Pipes Installed Capacity TPA ・Standalone data |
||||||||||
| Caustic Soda Capacity Utilisation % |
||||||||||
| Chemical Segment Revenue Share % ・Standalone data |
||||||||||
| ECU Realisation (Chlor-Alkali) INR/MT ・Standalone data |
||||||||||
| OPVC Pipes Capacity Utilisation % |
||||||||||
| OPVC Pipes Sales Volume kt |
||||||||||
| States Approved for OPVC Pipes count ・Standalone data |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Approval Of The Un-Audited Financial Results Or The Quarter Ended 30Th June, 2026
23 Jul - Board meets 29 July 2026 to approve Q1 FY27 unaudited financial results; trading window closed till 31 July 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Jul - Submission of copies of newspaper advertisement on Notice of transfer of shares to IEPFA
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Jul - Cameo issued Regulation 74(5) compliance certificate for quarter ended 30 June 2026.
-
Closure of Trading Window
26 Jun - Trading window closed from 1 July 2026 until 48 hours after Q1 FY27 results announcement.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 Jun - Submission of copies of newspaper advertisement on Notice of transfer of shares to IEPFA.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
CAL is an ISO 14001 and OHSAS 18001 certified manufacturer of choloro alkali products. It uses Membrane Technology for Chloralkali production. Company also produces chlorine, hydrogen, sodium hypo chlorite, and hydrochloric acid as by-products from manufacture of caustic soda